Assessment of Quality of Life of Cervical Cancer Patients Using ECOG-Performance Status Scale

Main Article Content

Shubham Lingappanoor
Geetha Rani Manupati
Vasthalya Meesala
Padma Yaragani
Brahmani Bachu
Shyam Sunder Anchuri


Background: Cervical cancer is becoming one of the emerging health burdens for womenhood and India accounts for one-third of the cervical cancer deaths globally. More than 80% of women with cervical cancer are diagnosed at an advanced stage. In this study, we aimed to assess the Quality of Life (QOL) of patients with cervical cancer after treatment and to examine the factors affecting their QOL.

Materials and Methods: This is a retrospective observational study, included 218 cervical cancer patients. The study was conducted in a tertiary care hospital in Warangal of Telangana State. The impact of socioeconomic factors and clinical factors on the QOL of the patients were studied using Eastern Cooperative Oncology Group-Performance status (ECOG-PS) scale. The protocol was approved by KIEC-KMC, Warangal. The statistical analysis was performed by using Fischer's Exact test, a value of p<.05 was considered as significant.

Results: Out of 218 patients 189 were alive and 29 were deceased. Patient of age group 21-40 years, patients from urban areas, from upper socioeconomic status (SES), patients with literacy, without any social habits had good QOL, where as patients in labour forces had poor QOL and are statistically significant. Patients with early stage at diagnosis and patients underwent surgical treatment along with chemoradiation therapy had good QOL yet, these results are statistically insignificant.

Conclusion: The lack of access to preventive and definitive care by the health care sectors, poor socioeconomic status, educational status of the women and awareness regarding the disease and its treatment patterns resulted in poor follow up, low adherence to the treatment, which accentuated the cervical cancer burden. Hence, enhancing the above listed factors could be beneficial in improving QOL of cervical cancer patients.

Cervical cancer, chemoradiation, socioeconomic status, quality of life

Article Details

How to Cite
Lingappanoor, S., Manupati, G., Meesala, V., Yaragani, P., Bachu, B., & Anchuri, S. (2019). Assessment of Quality of Life of Cervical Cancer Patients Using ECOG-Performance Status Scale. Journal of Cancer and Tumor International, 9(3), 1-8.
Original Research Article


Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80: 827-41.

WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in India; 2007.
[Last Assessed on 2008 May 1]

Dinshaw KA, Rao DN, Ganesh B. Tata memorial hospital cancer registry annual report. Mumbai, India: Department of Biostatistics and Epidemiology, Tata Memorial Hospital. 1999;52.

Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening: Current knowledge & practice among women in a rural population of Kerala, India. Indian J Med Res. 2012;136:205-10.

Institute for Health Metrics and Evaluation. The Challenge Ahead: Progress in Breast and Cervical Cancer. Institute of Health Metrics and Evaluation; 2011.
[Last accessed on 2013 Jan 21]

Sankaranarayanan R, Black R, Parkin D. eds., Cancer survival in developing countries, France. IARC Scintific Publications; 1998.

Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, et al. Longterm trends in cancer mortality in the United States, 1930 –1998. Cancer. 2003; 97(12):3133–75.

Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673–84.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.

Carmo CC, Luiz RR. Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center. Rev Saúde Pública. 2011;45:661-67.

Pardo C, Cendales R. Supervivencia de pacientescon cáncer de cuellouterino-tratadas en el Instituto Nacional de Cancerología. Biomédica (Bogotá). 2009; 29:437-47.

Coker AL, Du XL, Fang S, Eggleston KS. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecol Oncol. 2006;102(2):278-84.

Bishop A, Sherris J, Tsu VD, Kilbourne-Brook M. Cervical dysplasia treatment: Key issues for developing countries. Bulletin of the Pan American Health Organization. 1996;30:378–86.

Schrijvers CT, Mackenbach JP. Cancer patient survival by socioeconomic status in seven countries: A review for six common cancer sites [corrected]. J Epidemiol Community Health. 1994;48(5):441-46.

Nandakumar A, Anantha N, Venugopal TC. Incidence, mortality and survival in cancer of the cervix in Bangalore, India. Br J Cancer. 1995;71(6):1348-52.

Munagala R, Rai SN, Ganesharajah S, Bala N, Gupta RC. Clinicopathological, but not socio-demographic factors affect the prognosis in cervical carcinoma. Oncol Rep. 2010;24(2):511-20.

Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer. 2007;31:157–81.

Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nohr B, Munk C, et al. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Eur J Cancer. 2008;44:2003–17.

Louwman WJ, Aarts MJ, Houterman S, van Lenthe FJ, Coebergh JW, Janssen-Heijnen ML. A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer. 2010;103:1742–48.

Yeole BB, Kumar AV, Kurkureet A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai. Asian Pac J Cancer Prev. 2004; 5:308–15.

Porchia, Leonardo, Meda E, Zepeda Rossana, Orduña-Salazar AA, Juárez-Salazar et al. Different effects of the RNASEL R462Q mutation on the risk of developing prostate and cervical cancer in Latin American subjects: A meta-analysis. J Carcinog Mutagen. 2015;6:234.

Klee M, Thranov I, Machin D. Life after radiotherapy: The psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol Oncol. 2000;76:5-13.

Zubrod CG, Ipsen J, Frei E, Lasagna LC, Lipsett MB, Gehan E, Escher GC. Newer techniques and some problems in cooperative group studies. Natl Cancer Inst Monogr. 1960;3:277–92

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mc Fadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 1993;67(4): 773–75.

Roila F, Lupattelli M, Sassi M, Basurto C, Bracarda S, Picciafuoco M. Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol. 1991;2:437–39.

Tulika Singh, Sanju Sharma, Seetharamiah Nagesh. Socio-economic status scales updated for 2017. Int J Res Med Sci. 2017;5(7):3264-67.

Fisher Exact Test – Physics.

Koopmanschap MA, van Ineveld BM, Miltenburg TE. Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screening. Soc. Sci. Med. 1992;35(8)979-85.

Irving ER and Mans DRA. Age and Ethnic Differences in the Occurrence of Cervical Dysplasia, Cervical Cancer, and Cervical Cancer Deaths in Suriname. Transl Biomed. 2015;6:1.

Michael Frumovitz, Charlotte C. Sun, Leslie R. Schover, Mark F. Munsell, Anuja Jhingran, J. Taylor Wharton, et al. Quality of Life and Sexual Functioning in Cervical Cancer Survivors. J Clin Oncol. 2005; 23:7428-36.

Grigsby PW, Perez CA, Kuske RR, Camel HM, Kao MS, Galakatos AE, et al. Adenocarcinoma of the uterine cervix: Lack of evidence for a poor prognosis. Radiother Oncol. 1988;12:289-96.

Kathryn Osann, Susie Hsieh, Edward L. Nelson, Bradley J. Monk, Dana chase, David Cella, factors associated with poor quality of life among cervical cancer survivors: Implications for clinical care and clinical trials, Gynecol Oncol. 2014;135(2): 266-72.

Saishree Pradhan, Sonali Sarkar, Subitha Lakshminarayanan. Quality of life in cervical cancer patients on follow-up care in a regional cancer center in south India. National Journal of Research in Community Medicine. 2015;4:1:139-50.

Niresh Thapa, Muna Maharjan, YanXiong, Daqiong Jiang, Thi-Phuong Nguyen, Marcia A. Petrini. Impact of cervical cancer on quality of life of women in Hubei, China. Scientific Reports. 2018;8:11993.

Sarikapan Wilailak, Arb-aroon Lertkhachonsuk, Nawaporn Lohacharoenvanich, Suteera Chukkul Luengsukcharoen, Manmana Jirajaras, Puchong Likitanasombat, et al. Quality of life in gynecologic cancer survivors compared to healthy check-up women. J Gynecol Oncol. 2011;22(2)103-109.

Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol. Oncol. 2006;100(3):479-486.

Howard P. Greenwald, Ruth Mc Corkle, Kathy Baumgartner, Carolyn Gotay, Anne Victoria Neale. Quality of life and disparities among long-term cervical cancer survivors J Cancer Surviv. 2014; 8:419–26.

Bindu T, Kumar SS, Ratheesan K, Balasubramanian S. Factors associated with survival and lost to follow-up of cervical cancer patients in a tertiary cancer centre in rural Kerala. Indian J Public Health. 2017;61:43-46.

Waggoner SE, Darcy KM, Fuhrman B, Parham G, Lucci J 3rd, Monk BJ, et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study. Gynecoloncol. 2006;103(3)853-58.